ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs–threshold doses for tissue reactions in a …
FA Stewart, AV Akleyev, M Hauer-Jensen, JH Hendry… - Annals of the ICRP, 2012 - Elsevier
This report provides a review of early and late effects of radiation in normal tissues and
organs with respect to radiation protection. It was instigated following a recommendation in …
organs with respect to radiation protection. It was instigated following a recommendation in …
[HTML][HTML] Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy …
NM Kuderer, DC Dale, J Crawford… - Database of Abstracts of …, 2007 - ncbi.nlm.nih.gov
The authors concluded that prophylactic granulocyte colony-stimulating factors reduce the
risk of febrile neutropenia and early death in adults with solid tumours and malignant …
risk of febrile neutropenia and early death in adults with solid tumours and malignant …
[PDF][PDF] Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update
RA Taplitz, EB Kennedy, EJ Bow… - Journal of Clinical …, 2018 - canhgiacduoc.org.vn
Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression:
ASCO and IDSA Clinical Practice Guideline Up Page 1 JOURNAL OF CLINICAL …
ASCO and IDSA Clinical Practice Guideline Up Page 1 JOURNAL OF CLINICAL …
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America
AG Freifeld, EJ Bow, KA Sepkowitz… - Clinical infectious …, 2011 - academic.oup.com
This document updates and expands the initial Infectious Diseases Society of America
(IDSA) Fever and Neutropenia Guideline that was published in 1997 and first updated in …
(IDSA) Fever and Neutropenia Guideline that was published in 1997 and first updated in …
Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical …
CR Flowers, J Seidenfeld, EJ Bow, C Karten… - Journal of clinical …, 2013 - ascopubs.org
Purpose To provide guidelines on antimicrobial prophylaxis for adult neutropenic oncology
outpatients and on selection and treatment as outpatients of those with fever and …
outpatients and on selection and treatment as outpatients of those with fever and …
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult …
MS Aapro, J Bohlius, DA Cameron, L Dal Lago… - European journal of …, 2011 - Elsevier
Chemotherapy-induced neutropaenia is a major risk factor for infection-related morbidity
and mortality and also a significant dose-limiting toxicity in cancer treatment. Patients …
and mortality and also a significant dose-limiting toxicity in cancer treatment. Patients …
[HTML][HTML] ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer
A Passaro, A Addeo, C Von Garnier, F Blackhall… - ESMO open, 2020 - Elsevier
The COVID-19 pandemic, characterised by a fast and global spread during the first months
of 2020, has prompted the development of a structured set of recommendations for cancer …
of 2020, has prompted the development of a structured set of recommendations for cancer …
Impact of chemotherapy dose intensity on cancer patient outcomes
GH Lyman - Journal of the National Comprehensive Cancer …, 2009 - jnccn.org
Chemotherapy dose intensity represents unit dose of chemotherapy administered per unit
time. Dose intensity can be increased or decreased through altering dose administered, time …
time. Dose intensity can be increased or decreased through altering dose administered, time …
Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy
GH Lyman, NM Kuderer, J Crawford, DA Wolff… - Cancer, 2011 - Wiley Online Library
BACKGROUND: A prospective cohort study was undertaken to develop and validate a risk
model for neutropenic complications in cancer patients receiving chemotherapy. METHODS …
model for neutropenic complications in cancer patients receiving chemotherapy. METHODS …
Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology
H Wildiers, I Kunkler, L Biganzoli, J Fracheboud… - The lancet …, 2007 - thelancet.com
Breast cancer is the most commonly diagnosed cancer and the leading cause of cancer
mortality in women worldwide. Elderly individuals make up a large part of the breast cancer …
mortality in women worldwide. Elderly individuals make up a large part of the breast cancer …